Most firms have set up a war room to triage their immediate response to the crisis. But the lack of visibility around future demand complicates efforts to restart stalled portfolio companies…

Most firms have set up a war room to triage their immediate response to the crisis. But the lack of visibility around future demand complicates efforts to restart stalled portfolio companies…

We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for; Ricovir-EM® (tenofovir/emtricitabine) 300mg/200mg film-coated Tablets, 30s HDPE bottle Ricovir-EM® is a double combination therapy for the treatment of HIV-1 infected adults. Mylan is committed to manufacturing low-cost, high-quality generics thus contributing to affordable healthcare. Mylan is also involved in […]

We are pleased to announce Pharma Solutions exclusive partnership with Aurobindo Pharma, one of the largest Pharmaceutical companies in India with a global footprint. Pharma Solutions will exclusively market & distribute Aurobindo Oncology products in key treatment centers in the UAE.

As part of our ambitious plans, we expect to file many critical-care molecules for regulatory approvals at the UAE MoHAP.

Retroactive, March 20th, 2018, Helsinn acquired worldwide rights to Valchlor/Ledaga, an alkalyting agent for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma (MF-CTCL) from Actelion Pharmaceuticals Ltd. More details in this link.

Penthrox® is now approved for sale in Sweden, Norway, Poland and Croatia. More details in this link

We have the pleasure to announce the UAE Ministry of Health & Prevention (MoHAP) approval for our two new products: Avitaze (efavirenz) film-coated Tablets, 30s HDPE bottle Tenarta (tenofovir) film-coated Tablets, 30s HDPE bottle Avitaze is prescribed for the treatment of HIV. Tenarta is prescribed for the treatment of HBV & HIV. Mylan is committed […]

The UAE MoHAP has endorsed �Pharma Solutions LLC� as the exclusive distributor of �Les Laboratoires Medis S.A., Tunisia�. The following products are governed under this endorsement: Medicaine® 2% solution for injection MP-40® powder & solvent for solution for injection Flukas® 100mg/50ml solution for injection Flukas® 200mg/100ml solution for injection Levoflox® 5mg/ml solution for infusion More […]

The UAE Ministry of Health & Prevention (MoHAP) has approved Xonrid® Gel, a topical gel for radiotherapy-induced dermatitis, already classified as a medical device in the EU, and has received 510(K) FDA clearance in the US. Radiotherapy-induced dermatitis or Radiation dermatitis is a side effect of external beam ionizing radiation. It is also called radiodermatitis, […]